---
title: "APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP — Ownership Dossier"
canonical: https://whiteintel.dev/entity/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f
json: https://whiteintel.dev/api/public/dossier/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f
identifier: sec:0001399779
jurisdiction: US
risk: Low
source: WhiteIntel corporate-ownership graph
---

# APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP

**Type:** Company  
**Jurisdiction:** [US](https://whiteintel.dev/jurisdictions/us)  
**Identifier:** `sec:0001399779`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f  

## Ownership & control

### Holdings / subsidiaries

- **BG MEDICINE, INC.** (tenpercentowner) — https://whiteintel.dev/entity/0f4672dd-1e95-5b7b-a30c-3d13f5fb151a
- **ACCELERON PHARMA INC** (tenpercentowner) — https://whiteintel.dev/entity/2902d974-49e7-59b3-b374-8b3b3339dcb2
- **HELICOS BIOSCIENCES CORP** (tenpercentowner) — https://whiteintel.dev/entity/9d7f63d8-f365-577a-91b0-da7b4dae670f
- **HELICOS BIOSCIENCES CORP** (director) — https://whiteintel.dev/entity/9d7f63d8-f365-577a-91b0-da7b4dae670f

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **APPLIED GENOMIC TECHNOLOGY CAPITAL FUND LP**. Human view: https://whiteintel.dev/entity/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f · Structured JSON: https://whiteintel.dev/api/public/dossier/3d26ba2b-a099-55c6-be63-ebe7fec7ab0f._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._